Skip to main content

Leukemia

  • Chapter
  • 134 Accesses

Part of the book series: UICC International Union Against Cancer ((UICCI))

Abstract

Leukemias represent 3% of all cancers in the world with relatively little variation between regions or countries. In many countries, leukemias are the most common cancer in children under 15, accounting for one third of all new cases. Cancer registries record leukemias under seven rubrics: acute lymphocytic (ALL), chronic lymphocytic (CLL), acute myeloid (AML), chronic myeloid (CML), monocytic (ML), other leukemias, and unspecified. The accuracy and the use of this classification varies from country to country, thus making comparisons difficult. With this in mind, the most striking features of the descriptive epidemiology are the low rates for CLL in China, Japan, and India and the apparent high risk for AML among the populations in the Pacific Islands. Age is strongly associated with leukemia type, ALL being a disease of childhood and CLL a disease of the elderly. The age distribution among children under 15 shows a peak between the ages of 2 and 4 years, which is more pronounced among whites than among blacks. Blacks in the US show lower rates than whites, and African children seem to have very low rates with no evidence of a peak between the ages of 2 and 4. Almost universally, males are more affected than females with a ratio of 2:1.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Further Reading

  • Champlin R, Gale RP (1987) Acute myelogenous leukemia: recent advances in therapy. Blood 69: 1551–1562

    PubMed  CAS  Google Scholar 

  • Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia (1988) Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. N Engl J Med 319: 902–907

    Article  Google Scholar 

  • Drexler HG, Gignac SM, Minowada J (1988) Routine immunophenotyping of acute leukemias. Blut 57: 327–339

    Article  PubMed  CAS  Google Scholar 

  • Fearon ER, Burke PJ, Schiffer CA, Zehnbauer BA, Vogelstein B (1986) Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. N Engl J Med 315: 15–24

    Article  PubMed  CAS  Google Scholar 

  • Gale RP, Kanti RR (1987) New insight into a chronic lymphocytic leukemia. Leukemia 1: 677–679

    PubMed  CAS  Google Scholar 

  • Griesser H, Tkachuk G, Reis MD, Mak TW (1989) Gene rearrangements and translocation in lymphoproliferative diseases. Blood 73: 1402–1415

    PubMed  CAS  Google Scholar 

  • Holzer D, Gale RP (1987) Acute lymphoblastic leukemia in adults: recent progress and future directions. Semin Hematol 24: 27–54

    Google Scholar 

  • International Workshop on Chronic Lymphocytic Leukemia (1989) Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. Ann Intern Med 110: 236–238

    Google Scholar 

  • Kurzrock R, Gutterman JU, Talpaz M (1988) The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 319: 990–998

    Article  PubMed  CAS  Google Scholar 

  • Montserrat E, Rozman C (1987) Bone marrow biopsy in chronic lymphocytic leukemia: a review of its prognostic importance. Blood Cells 12: 315–326

    PubMed  CAS  Google Scholar 

  • Riehm H, Flickert HJ, Laupert F (1986) Acute lymphoblastic leukemia. In: Voute PA et al (eds) Cancer in children. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Second MIC Cooperative Group (1988) Morphologic, immunologic and cytogenetic (MIC) working classification of acute myeloid leukaemias. Br J Haematol 68: 487–494

    Article  Google Scholar 

  • Simon W, Segel GB, Lichtman MA (1988) Upper and lower time limits in the decision to recommend marrow transplantation for patients with chronic myelogenous leukemia. Br J Haematol 70: 31–36

    Article  PubMed  CAS  Google Scholar 

  • Sokal JE, Baccarani M, Russo D, Tura S (1988) Staging and prognosis in chronic myelogenous leukemia. Semin Hematol 25: 49–61

    PubMed  CAS  Google Scholar 

  • Talpaz M, Kantarjian HM, Kurzrock R, Gutterman J (1988) Therapy of chronic myelogenous leukemia: chemotherapy and interferons. Semin Hematol 25: 62–73

    PubMed  CAS  Google Scholar 

  • Toronto Leukemia Study Group (1986) Results of chemotherapy for unselected patients with acute myeloblastic leukemia: effect of exclusions on interpretation of results. Lancet I: 786–788

    Google Scholar 

  • Travade P, Chastang C, Dighiero G, Binet JL, Cooperative Group on CLL of Société Française d’Hématologie (1987) New trends in CLL treatment. Blood Cells 12: 485–496

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hossfeld, D.K. (1982). Leukemia. In: Sherman, C.D., Hossfeld, D.K., Love, R.R., Bosch, F.X. (eds) Manual of Clinical Oncology. UICC International Union Against Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97267-6_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97267-6_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-52769-5

  • Online ISBN: 978-3-642-97267-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics